Brazen Capital is launching the next generation of scientist-CEOs at the earliest stages of their startup journey in biomedicine. Our unique value-add is we (co-GPs Shawn Carbonell, MD, PhD and Monica Berrondo, PhD [YC W18]) have been scientist-CEOs ourselves for over a decade each. Unlike most VCs, we've lived that life. Brad Heller, PhD and I met randomly in November 2021 on LunchClub, of all places. This was a time before we had even launched the fund, but after listening to him passionately explain what he was working on during that short video conference call, I placed him in my mental pipeline of founders to potentially invest in. Over the subsequent months, what Monica and I confirmed is this is an impressive founder leveraging his deep technical expertise to solve a major problem he personally identified while working in the cell therapy industry. With the addition of highly experienced biotech executive and cofounder, Paul Chun, we are extremely bullish about their potential for dramatically improving patient outcomes in the multi-billion dollar cell therapy space. We are proud to be the first investors in Achieve Clinics and welcome you to join us. W. Shawn Carbonell, MD, PhD Founding Partner, Brazen Capital